Coming Full Circle in Diabetes Mellitus: from Complications to Initiation

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2013 Jan 9

PMID 23296171

Citations 40

Authors

Brooke E Harcourt

Sally A Penfold

Josephine M Forbes

Affiliations

Soon will be listed here.

Abstract

Glycaemic control, reduction of blood pressure using agents that block the renin-angiotensin system and control of dyslipidaemia are the major strategies used in the clinical management of patients with diabetes mellitus. Each of these approaches interrupts a number of pathological pathways, which directly contributes to the vascular complications of diabetes mellitus, including renal disease, blindness, neuropathy and cardiovascular disease. However, research published over the past few years has indicated that many of the pathological pathways important in the development of the vascular complications of diabetes mellitus are equally relevant to the initiation of diabetes mellitus itself. These pathways include insulin signalling, generation of cellular energy, post-translational modifications and redox imbalances. This Review will examine how the development of diabetes mellitus has come full circle from initiation to complications and suggests that the development of diabetes mellitus and the progression to chronic complications both require the same mechanistic triggers.

Citing Articles

Deep Immune and RNA Profiling Revealed Distinct Circulating CD163+ Monocytes in Diabetes-Related Complications.

Siwan E, Wong J, Brooks B, Shinko D, Baker C, Deshpande N Int J Mol Sci. 2024; 25(18).

PMID: 39337580 PMC: 11432403. DOI: 10.3390/ijms251810094.

Association of COVID-19 infection and the risk of new incident diabetes: a systematic review and meta-analysis.

Zhou J, Wang Y, Xu R Front Endocrinol (Lausanne). 2024; 15:1429848.

PMID: 39253580 PMC: 11381376. DOI: 10.3389/fendo.2024.1429848.

Association of body iron stores and anemia in a Ghanaian type-2 diabetes mellitus population: A multicentered cross-sectional study.

Boadu W, Owiredu W, Donkoh E, Boadu K, Kwayie A, Frimpong J Health Sci Rep. 2024; 7(5):e2059.

PMID: 38725560 PMC: 11079434. DOI: 10.1002/hsr2.2059.

Characteristics of glucolipid metabolism and complications in novel cluster-based diabetes subgroups: a retrospective study.

Li X, Chen H Lipids Health Dis. 2023; 22(1):200.

PMID: 37990237 PMC: 10662503. DOI: 10.1186/s12944-023-01953-6.

Extracellular vesicle-mediated intercellular and interorgan crosstalk of pancreatic islet in health and diabetes.

Wei J, Wang Z, Han T, Chen J, Ou Y, Wei L Front Endocrinol (Lausanne). 2023; 14:1170237.

PMID: 37305058 PMC: 10248434. DOI: 10.3389/fendo.2023.1170237.

References

Ijaz A, Tejada T, Catanuto P, Xia X, Elliot S, Lenz O . Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney Int. 2008; 75(4):381-8. DOI: 10.1038/ki.2008.559. View

Baggio L, Huang Q, Brown T, Drucker D . A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes. 2004; 53(9):2492-500. DOI: 10.2337/diabetes.53.9.2492. View

Wolf G, Ziyadeh F . Leptin and renal fibrosis. Contrib Nephrol. 2006; 151:175-183. DOI: 10.1159/000095328. View

Ahren B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson P . Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care. 2002; 25(5):869-75. DOI: 10.2337/diacare.25.5.869. View

Dabelea D, Bell R, DAgostino Jr R, Imperatore G, Johansen J, Linder B . Incidence of diabetes in youth in the United States. JAMA. 2007; 297(24):2716-24. DOI: 10.1001/jama.297.24.2716. View

Xie J, Herbert T . The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes. Cell Mol Life Sci. 2011; 69(8):1289-304. PMC: 11114779. DOI: 10.1007/s00018-011-0874-4. View

Leney S, Tavare J . The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets. J Endocrinol. 2009; 203(1):1-18. DOI: 10.1677/JOE-09-0037. View

Bruning J, Michael M, Winnay J, Hayashi T, Horsch D, Accili D . A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell. 1998; 2(5):559-69. DOI: 10.1016/s1097-2765(00)80155-0. View

Ward K, Mahan J, Sherman W . Aerobic training and diabetic nephropathy in the obese Zucker rat. Ann Clin Lab Sci. 1994; 24(3):266-77. View

10.

Carraro-Lacroix L, Malnic G, Girardi A . Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal Physiol. 2009; 297(6):F1647-55. DOI: 10.1152/ajprenal.00082.2009. View

11.

Baekkeskov S, Nielsen J, Marner B, Bilde T, Ludvigsson J, Lernmark A . Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982; 298(5870):167-9. DOI: 10.1038/298167a0. View

12.

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M . Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106(16):2067-72. DOI: 10.1161/01.cir.0000034509.14906.ae. View

13.

Unger R . Lipotoxic diseases. Annu Rev Med. 2002; 53:319-36. DOI: 10.1146/annurev.med.53.082901.104057. View

14.

Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

15.

Laukkanen O, Lindstrom J, Eriksson J, Valle T, Hamalainen H, Ilanne-Parikka P . Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes. 2005; 54(7):2256-60. DOI: 10.2337/diabetes.54.7.2256. View

16.

Rahmoune H, Thompson P, Ward J, Smith C, Hong G, Brown J . Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005; 54(12):3427-34. DOI: 10.2337/diabetes.54.12.3427. View

17.

Todd J . A protective role of the environment in the development of type 1 diabetes?. Diabet Med. 1991; 8(10):906-10. DOI: 10.1111/j.1464-5491.1991.tb01528.x. View

18.

Sasaoka T, Rose D, Jhun B, Saltiel A, Draznin B, Olefsky J . Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem. 1994; 269(18):13689-94. View

19.

Kitamura T, Kahn C, Accili D . Insulin receptor knockout mice. Annu Rev Physiol. 2002; 65:313-32. DOI: 10.1146/annurev.physiol.65.092101.142540. View

20.

Nangaku M, Izuhara Y, Usuda N, Inagi R, Shibata T, Sugiyama S . In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant. 2005; 20(12):2661-9. DOI: 10.1093/ndt/gfi096. View